INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 1 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,902 | -21.6% | 4,889,500 | -10.1% | 0.00% | 0.0% |
| Q2 2023 | $2,427 | +12.1% | 5,436,281 | +105.9% | 0.00% | 0.0% |
| Q1 2023 | $2,165 | -46.1% | 2,640,300 | +2.6% | 0.00% | -40.0% |
| Q4 2022 | $4,013 | -99.9% | 2,572,500 | +10.7% | 0.01% | -16.7% |
| Q3 2022 | $4,008,000 | +46.9% | 2,323,700 | +47.3% | 0.01% | +100.0% |
| Q2 2022 | $2,729,000 | +93.0% | 1,577,500 | +300.5% | 0.00% | +50.0% |
| Q1 2022 | $1,414,000 | -68.5% | 393,881 | -34.7% | 0.00% | -50.0% |
| Q1 2020 | $4,487,000 | +278.3% | 603,123 | +67.8% | 0.00% | +300.0% |
| Q4 2019 | $1,186,000 | +328.2% | 359,500 | +166.5% | 0.00% | – |
| Q3 2019 | $277,000 | -56.1% | 134,900 | -37.2% | 0.00% | -100.0% |
| Q2 2019 | $631,000 | -70.0% | 214,681 | -62.0% | 0.00% | -50.0% |
| Q1 2019 | $2,105,000 | +57.0% | 564,281 | +68.3% | 0.00% | +100.0% |
| Q4 2018 | $1,341,000 | -35.7% | 335,281 | -10.7% | 0.00% | -50.0% |
| Q3 2018 | $2,087,000 | -27.3% | 375,381 | -43.2% | 0.00% | 0.0% |
| Q2 2018 | $2,869,000 | +74.2% | 661,462 | +89.1% | 0.00% | 0.0% |
| Q1 2018 | $1,647,000 | +9.6% | 349,781 | -3.9% | 0.00% | 0.0% |
| Q4 2017 | $1,503,000 | -43.0% | 363,981 | -7.3% | 0.00% | -66.7% |
| Q4 2015 | $2,639,000 | – | 392,781 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Round Table Services, LLC | 129,500 | $1,207,000 | 0.72% |
| STONERIDGE INVESTMENT PARTNERS LLC | 252,376 | $2,352,000 | 0.34% |
| Bellevue Group AG | 155,000 | $1,445,000 | 0.26% |
| WASATCH ADVISORS LP | 1,861,553 | $17,350,000 | 0.26% |
| Blue Clay Capital Management, LLC | 13,000 | $121,000 | 0.14% |
| Virtus ETF Advisers LLC | 24,058 | $224,000 | 0.11% |
| EMERALD ADVISERS, LLC | 203,737 | $1,899,000 | 0.08% |
| Vident Investment Advisory, LLC | 63,383 | $591,000 | 0.08% |
| Thomas J. Herzfeld Advisors, Inc. | 15,000 | $140,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 94,400 | $880,000 | 0.05% |